{"product_id":"fragment-modified-grf-ipamorelin-blend","title":"Fragment, Modified GRF, Ipamorelin Blend","description":"\u003cp data-end=\"808\" data-start=\"139\"\u003eFragment \/ Modified GRF \/ Ipamorelin Blend is a research peptide formulation combining three well-studied synthetic peptides commonly examined in growth hormone and endocrine signaling research: Fragment (176–191), Modified GRF (1–29), and Ipamorelin. Fragment (176–191) is a modified C-terminal fragment of human growth hormone, while Modified GRF (1–29) is a stabilized analog of growth hormone–releasing hormone (GHRH). Ipamorelin is a selective growth hormone secretagogue receptor (GHS-R) agonist. Together, this blend is formulated for laboratory research focused on growth hormone signaling, metabolic pathways, and coordinated endocrine response mechanisms.\u003c\/p\u003e\n\u003cp data-end=\"1611\" data-start=\"810\"\u003ePrior to the targeted synthesis and study of these peptides, research into growth hormone modulation and metabolic signaling relied largely on less specific hormonal interventions and generalized secretagogues. In controlled research settings, Fragment (176–191) has been studied for its role in lipid metabolism–related signaling pathways. Modified GRF (1–29) has been researched for its ability to stimulate endogenous growth hormone release via GHRH receptor activation while maintaining a short duration of activity. Ipamorelin has been examined for its selective receptor activity and minimal interaction with other pituitary hormones. The combination allows researchers to explore complementary mechanisms involved in growth hormone pulsatility, metabolic regulation, and endocrine coordination.\u003c\/p\u003e\n\u003cp data-end=\"2191\" data-start=\"1613\"\u003eCurrently, the Fragment \/ Modified GRF \/ Ipamorelin Blend is being investigated for potential applications in metabolic research models, endocrine pathway analysis, recovery-related signaling studies, and age-associated hormone regulation research. Additional investigation continues into its role in downstream anabolic and metabolic signaling processes, circadian hormone release patterns, and coordinated pituitary response mechanisms. Due to the complementary research interest of these peptides, this blend remains a compelling subject for ongoing laboratory investigation.\u003c\/p\u003e\n\u003cp data-end=\"2432\" data-start=\"2193\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2432\" data-start=\"2193\"\u003e \u003c\/p\u003e\n\u003cp data-end=\"2432\" data-start=\"2193\"\u003eThe primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.\u003c\/p\u003e\n\u003cp data-end=\"2856\" data-start=\"2434\"\u003eTHIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.\u003c\/p\u003e","brand":"Nordsci","offers":[{"title":"Default Title","offer_id":52900975575358,"sku":null,"price":95.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0788\/4626\/3614\/files\/Fragment_Modified_GRF_Ipamorelin_Blend_5d44aff3-4696-4980-9f03-e08fa040a832.png?v=1768874010","url":"https:\/\/nordscipeptides.com\/products\/fragment-modified-grf-ipamorelin-blend","provider":"Nordsci","version":"1.0","type":"link"}